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Abstract
Background: Acute respiratory distress syndrome (ARDS) is multifactorial and can result from sepsis, trauma, or
pneumonia, amongst other primary pathologies. It is one of the major causes of death in critically ill patients with a
reported mortality rate up to 45%. The present study focuses on the development of a large animal model of smoke
inhalation-induced ARDS in an effort to provide the scientific community with a reliable, reproducible large animal
model of isolated toxic inhalation injury-induced ARDS.
Methods: Animals (n = 21) were exposed to smoke under general anesthesia for 1 to 2 h (median smoke exposure = 0.5 to 1 L of oak wood smoke) after the ultrasound-guided placement of carotid, pulmonary, and femoral artery
catheters. Peripheral oxygen saturation (SpO2), vital signs, and ventilator parameters were monitored throughout the
procedure. Chest x-ray, carotid, femoral and pulmonary artery blood samples were collected before, during, and after
smoke exposure. Animals were euthanized and lung tissue collected for analysis 48 h after smoke inhalation.
Results: Animals developed ARDS 48 h after smoke inhalation as reflected by a decrease in S pO2 by approximately
31%, PaO2/FiO2 ratio by approximately 208 (50%), and development of bilateral, diffuse infiltrates on chest x-ray. Study
animals also demonstrated a significant increase in IL-6 level, lung tissue injury score and wet/dry ratio, as well as
changes in other arterial blood gas (ABG) parameters.
Conclusions: This study reports, for the first time, a novel large animal model of isolated smoke inhalation-induced
ARDS without confounding variables such as cutaneous burn injury. Use of this unique model may be of benefit in
studying the pathophysiology of inhalation injury or for development of novel therapeutics.
Keywords: Smoke inhalation, ARDS, Large animal model, Toxic inhalation injury, Hypoxia, Hypoxemia
Introduction
Acute respiratory distress syndrome (ARDS) is a serious pulmonary condition in critically ill patients with
a reported mortality rate ranging from 30–45% [1, 2].
There has been no significant change in the mortality
rate since 1994 [2]. ARDS can be caused by a variety of
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direct and indirect injuries to the lung, including sepsis,
trauma, pneumonia and smoke inhalation/burn injury
[3–5]. Understanding the pathophysiological and molecular mechanisms of ARDS is critical for the development
of novel therapeutic strategies for ARDS.
ARDS was coined by Ashbaugh et al. in 1967 to
describe an acute onset of tachypnea, hypoxemia, and
loss of compliance after a variety of insults [6]. The most
current consensus definition for ARDS in clinical setting was published in 2012 as the Berlin criteria [7]. The
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Berlin criteria base categorization of ARDS on level of
hypoxemia measured by the PaO2/FiO2 (arterial oxygen
partial pressure/fraction of inspired oxygen) ratio, positive end-expiratory pressure (PEEP) level, development
of bilateral pulmonary infiltrates on chest x-ray, and normal pulmonary capillary wedge pressure (PCWP) within
a week of a known clinical insult [7]. The lung injury in
ARDS has been reported to undergo three pathophysiological phases: the exudative phase involves damage to
the alveolar epithelium leading to increased lung permeability; the proliferative phase involves type II cell proliferation with epithelial cell regeneration, fibroblastic
reaction, and remodeling; and the irreversible fibrotic
phase, which includes collagen deposition in the lung
[8–10]. To understand the development of ARDS, reliable
animal models that can mimic these pathophysiological phases are critical. Previous studies have used mouse
models for assessment of pulmonary gas exchange and
respiratory physiology following controlled induction of
ARDS [11, 12]. However, these mouse models have limitations in the induction of mechanical ventilation and
collection of blood samples, and are therefore, not amenable for prolonged study essential to mimic the clinical
presentations of ARDS. Large animal models have been
reported to show better translational potential in the
study of ARDS. Swine models are considered an excellent
model for pulmonary pathology due to the similarities
with humans in terms of anatomy, genetics and physiology [13]. Various studies have used swine models to study
lung development [14, 15], acute lung injury (ALI)/ARDS
[16, 17] and other diseases.
Smoke inhalation is one of the major causes for the
development of ARDS after burn injury, with an approximate 30–90% mortality rate [18, 19]. Several large animal models are available for smoke/burn injury-induced
ARDS [20–22]. However, at present, there is no suitable
large animal model available to study isolated smoke
inhalation-induced ARDS without confounding variables
such as cutaneous burn injury.
The rate of ARDS after smoke inhalation injury varies
from patient to patient and is dependent upon several
variables such as particulate matter concentration, carbon monoxide concentration, volatile compounds in the
smoke, etc. Smoke inhalation injury is the primary injury
leading to acute lung injury/ARDS in humans involved
in house fires; the presence/absence of cutaneous burn
injury plays an additive role in the patient’s overall pathophysiology which significantly complicates the medical and surgical management of this patient population.
Exposure to indoor air pollution from biomass combustion—as seen during combustion of biomass fuels for
cooking and heating used by approximately half of all
people in developing countries—is a major source of
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morbidity and mortality worldwide and continues to be
an area of interest for research. As well, the detrimental
effect of prolonged exposure to acutely elevated levels of
environmental smoke from wildfires or house fires has
long-standing interest, especially when studying workplace hazards of firefighters. The main goal of our work
presented in the current manuscript was to study isolated
smoke inhalation injury without confounding variables
such as cutaneous burn, in an attempt to add to current
published literature in a way that would be translatable to
many real-life situations.
We have developed a large animal, isolated smoke
inhalation model to use in our investigations of molecular modification after smoke inhalation and novel therapeutic agents. In the study, pigs were exposed to smoke
directly through an endotracheal route to induce lung
injury in a controlled environment. Invasive and noninvasive parameters including vital signs, arterial blood
gas analysis, and chest x-rays were monitored to pinpoint the development of significant ARDS. IL-6 and
histological analysis were performed to understand the
pathophysiological profile critical for the development of
ARDS in these animals. To our knowledge, this is the first
study to develop and detail a large animal model of isolated smoke inhalation-induced ARDS.

Methods
Subjects

All the experiments involving animals were approved
by University of Nebraska Lincoln (UNL) Institutional
Animal Care and Use Committee (IACUC) (protocol #
1674). Female pigs (~ 50 kg, n = 21) were housed in pens
and cared for according to USDA (United States Department of Agriculture) guidelines. To our knowledge,
female pigs do not have higher susceptibility to ARDS
compared to male pigs. Our research collaborators had
previously developed a porcine model of severe ARDS
from intratracheal lipopolysaccharide using female pigs
only, and our use of female pigs in the current study was,
in part, to assess reliability and reproducibility in their
model using a contrasting lung injury.
Animals were acclimated to the facility for 4–7 days
and received food reward training to ease handling and
blood draws. Six animals died during the experiments
due to either anesthesia/surgical complications or smoke
inhalation related complication. We continued our next
phase of study (involving efficacy of a novel therapeutic
for hypoxia) in some of these animals to reduce cost and
number of animals used.
Smoke delivery system

Upon completion of all surgical procedures, animals were
exposed to oak wood smoke from a custom-made smoke
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generator connected in parallel to the endotracheal tube.
Schematic of the smoke delivery system is shown in
Fig. 1.
Surgical procedures

Sedation for peripheral intravenous catheter (PIV) placement and endotracheal intubation was achieved with a
mixture of telazol (4.4 mg/kg), ketamine (2.2 mg/kg) and
xylazine (2.2 mg/kg) delivered via intramuscular injection. To assist with intubation, an intravenous bolus dose
of fentanyl (0.05 mg/kg) and/or propofol (2–4.4 mg/kg)
was given as needed. Baseline chest x-rays were obtained
(portable x-ray unit EPX-F2800, Ecotron Co. Ltc; wireless
digital flat panel detector Mars1417V-TSI, iRay Technology, Shanghai, China) prior to smoke inhalation, and at
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24 and 48 h after smoke inhalation. An endotracheal tube
(#7–8 cuffed; MWI Animal Health, Boise, ID, USA) was
inserted into the trachea and animals were ventilated at
a tidal volume (TV) of 6 mL/kg and PEEP of 5 c mH2O
(Newport HT70, Medtronic, Minneapolis, MN). Respiratory rate (RR) was adjusted to maintain eucapnia as monitored by end-tidal C
 O2 (ETCO2). The fraction of inspired
oxygen (FiO2) was set at 50% during surgical procedures
(central venous & arterial catheter placement), then
titrated down to 21% and maintained throughout the
experiment. 50% F
 iO2 was used to reduce stress to animal during surgical procedures and lasted for 30–40 min.
Non-invasive monitoring included blood pressure taken
by cuff placed around the animal’s hind leg, peripheral
oxygen saturation (SpO2), heart rate (HR) and ETCO2

Fig. 1 Schematic diagram of the smoke generator system and delivery circuit

Leiphrakpam et al. Respir Res

(2021) 22:198

recorded via the Surgivet monitor (Smiths Medical, Dublin, OH). Continuous IV sedation containing midazolam
(0.4–0.7 mg/kg/h), fentanyl (0.03–0.1 mg/kg/h) and
propofol (0.2–0.4 mg/kg/min) and maintenance IV fluids
(10 mL/kg/h normal saline) were given throughout the
procedure via a quadruple-lumen central venous catheter
(8.5Fr × 16 cm, Arrow International) placed in the internal jugular vein. Core temperature was monitored by rectal probe and a circulating warming blanket was used to
prevent body cooling. A urinary catheter was placed to
monitor output.
Using sterile technique and ultrasound guidance (Butterfly iQ, Butterfly Network, New York City, NY), carotid
artery (CA) and femoral artery (FA) access catheters were
placed for serial lab draws and invasive blood pressure
monitoring (18 GA 16 cm; Femoral Arterial Line Catherization Kit; Teleflex, Morrisville, NC). Pulmonary artery
(PA) catheter (8F × 110 cm Swan-Ganz CCOmbo Thermodilution Catheter; Edwards Lifesciences, Irvine, CA)
was placed in the internal jugular vein under ultrasound
guidance. The CA and PA access ports were connected
to Surgivet monitor and Vigilance II monitor, respectively (Edwards Lifesciences, Irvine, CA) with transducers (Meritans DTXPlus, Disposable Pressure Transducer
with EasyVent; Merit Medical, South Jordan, UT, USA).
Invasive arterial blood pressure, central venous pressure
(CVP), pulmonary artery pressure (PAP), cardiac output
(CO), mixed venous oxygen saturation (SmvO2), and central (core) temperature were monitored throughout the
study. Blood samples were drawn from the CA, FA and
PA catheters for the measurement of baseline blood gas
prior to smoke inhalation and at pre-determined time
intervals throughout the study period (ABL80 FLEX
CO-OX, Radiometer, Brea, CA). To maintain patency,
catheters were flushed throughout the experiment with
3–5 mL of sterile saline, and a heparin solution (1:500
dilution in 50% dextrose solution) was infused to fill the
volume of the port chosen as a "lock" solution. Sedated/
anesthetized animals from survival surgeries were continuously monitored until sternal recumbence was
regained. All catheters were removed after smoke inhalation was completed. The surgical procedures were
repeated at 48 h after smoke inhalation.
Smoke inhalation

Upon completion of surgical procedures, animals in the
SI group were exposed to oak wood smoke from the custom-made smoke chamber (Fig. 1) through the endotracheal tube. The duration of the smoke exposure was 1
to 2 h starting from 0 h time point. Smoke was generated at room temperature (74–76 deg F) in a controlled
manner. Smoke density/particle load was not measured
in the current study. The volume of smoke inhaled was
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approximately 500 L per hour. Invasive and noninvasive parameters were monitored continuously during
the experiment. Following smoke exposure, blood samples were collected from arterial ports and PAC. Animal
was continuously monitored until recovery from general
anesthesia. Smoke exposure was stopped immediately if
the animal developed hemodynamic instability, which
was determined by hypotension (systolic blood pressure
less than 60) and irreversible desaturation 
(SpO2 less
than 70% despite rescue maneuvers such as increase in
inspired percentage of oxygen).
Ventilator parameters

On the day of the smoke inhalation, the ventilator
parameters were maintained at values: tidal volume,
6 mL/kg = 270-360L/min; respiratory rate, 18–30/min;
PEEP 5 mmHg; and FiO2, 21–34% (Table 1). During the
48 h after smoke inhalation injury, animals were extubated and maintained on room air.
At 48 h after smoke inhalation injury, animals were
again placed on the ventilator, surgical procedures of
catheter placement were repeated, serial lab, imaging,
and BAL sampling was completed, and animals were
humanely euthanized per IACUC protocols. On the final
study day, ventilator parameters were similar to the day of
smoke inhalation with the exception of maintaining PEEP
at 0. To reduce the effect of elevated mechanical power
applied to the lung, resulting in worsening of acute lung
injury through development of ventilator-induced lung
injury, we elected to avoid this potential confounder by
maintaining the PEEP at zero if drive pressure was noted
to be adequate and at safe levels. As noted in Swindle’s
authoritative reference (Swindle MM. Swine in the Laboratory: Surgery, Anesthesia, Imaging, and Experimental
Techniques. 2007, Second Edition, CRC Press), swine
have very fragile pulmonary tissue that can be damaged
by hyperinflation, and it is recommended to maintain
pressure between 11–20 cm H20. In our animals, drive
pressure was maintained in this range without use of
PEEP at 48 h post smoke inhalation injury.

Table 1 Ventilator parameters
Parameters

Baseline

SI 2 h

Post SI 24 h

Post SI 48 h

TV (mL/kg)

270–360

270–360

–

220–280

RR (bpm)

18–30

18–30

–

16–24

FiO2 (%)

21–34

21–34

21

21

PEEP (cmH2O)

5

5

–

0

SI, Smoke inhalation; TV, tidal volume; RR, respiratory rate; bpm, beats per
minute; FiO2, fraction of inspired oxygen; PEEP, positive end expiratory pressure
n = 13
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Post‑surgical animal monitoring and care

Lung injury score

After recovery from surgical anesthesia, all animals were
transferred to the post-surgery recovery pen and were
monitored 24 h/day by trained personnel. Chest x-rays
were taken and blood samples drawn for ABG analysis
at 24 h and 48 h following final smoke exposure. Animals (n = 7) were humanely euthanized at 48 h post SI
and a full necropsy was performed; the remainder of
animals were utilized to continue our lab’s therapeutic
investigations.

The lung tissue of all five lobes in 10% neutral formalin
was dehydrated in graded concentrations of ethanol solution and cleared in xylene. The tissue samples were then
paraffin-embedded, sectioned with 4-μm thickness, and
stained with hematoxylin and eosin at the UNMC Tissue Sciences Facility using automated Ventana Discovery Ultra (Roche Diagnostics, Indianapolis, IN) as per
manufacturer’s protocol. For each animal staining was
performed in five sections corresponding to the five
lobes of lung. An independent pathologist performed
a blinded examination of the tissues under light microscope. Ten fields of each lung tissue section were examined at magnification X400. The severity of the lung
injury was scored by the criteria of alveolar edema, intraalveolar hemorrhage, and leukocyte infiltration. Alveolar
edema and intra-alveolar hemorrhage were scored on a
scale from 0 to 3; where 0 ≤ 5% of maximum pathology,
1 = mild (< 10%), 2 = moderate (10–20%), and 3 = severe
(20–30%). Leukocyte infiltration was also scored on a
scale from 0 to 3; where 0 = absence of extravascular leukocytes, 1 ≤ 10, 2 = 10–45, and 3 ≥ 45 leukocytes.

Plasma sample extraction

Blood samples were collected from the CA catheter at
baseline, 2 h, and 48 h time points in lithium heparin
BD Microtainer tubes (Becton, Dickinson and Company,
Franklin Lakes, NJ). Tubes were immediately inverted
8–10 times to assure anticoagulation and centrifuged
at 4000g for 4 min. Supernatants were collected as
plasma samples and stored at − 80 °C until analysis. IL-6
immune assay was performed in samples of 10 animals
using IL-6 Quantikine® ELISA kit, catalog No#P6000B
(R&D Systems, Inc., Minneapolis, MN) on plasma samples following manufacturer’s protocol.
Bronchoalveolar lavage (BAL)

BAL of pig lungs was performed at baseline, 2 h, and 48 h
time points using a bronchoscope in a set of 6 intubated
animals. 10 ml of sterile normal saline was instilled to
the secondary and tertiary bronchi through the bronchoscope and ~ 5 ml of the fluid was collected for analysis. BAL fluid samples were centrifuged immediately at
400g at 4 °C for 10 min and supernatants were at stored
at − 80 °C until analysis. Total protein quantification was
performed in samples using Pierce™ BCA (Bicinchoninic
Acid) Protein Assay Kit (Thermo Fisher Scientific Inc.
Waltham, MA) following manufacturer’s protocol. IL-6
immune assay was performed using IL-6 Quantikine®
ELISA (Enzyme-linked immunosorbent assay) kit, catalog No#P6000B (R&D Systems, Inc., Minneapolis, MN)
on BAL fluid samples following manufacturer’s protocol.
Tissue collection

Necropsy was performed in 7 animals (control, n = 2; SI,
n = 5). At necropsy, lung tissues were collected from all
five lobes; upper, middle and lower lobes of right lung and
upper and lower lobes of left lung for histological examination and pulmonary edema assessment. Tissues for
histology were immediately placed in 10% neutral buffer
formalin fixative for approximately 24 h. Formalin fixed
tissues were placed into 70% ethanol and transferred to
the University of Nebraska Medical Center (UNMC) Tissue Science Facility (TSF) for further tissue processing
and embedment in paraffin blocks.

Wet‑to‑dry weight (W/D) ratio

Lung tissues (n = 6) were dried in an incubator at 60 °C
for 5 days and weighed again (dry weight). The W/D ratio
was calculated as the ratio of the wet weight to the final
dry weight as described elsewhere [23].
Ki67 immunohistochemistry

Immunostaining for Ki67 was performed on pig SI and
control formalin‐fixed, paraffin‐embedded lung tissues
sections using 1:200 concentration of Ki67 antibody
(#ab16667, Abcam Inc, Cambridge, MA) at UNMC Tissue Sciences Facility using automated Ventana Discovery
Ultra (Roche Diagnostics, Indianapolis, IN) in lung tissue samples of 5 animals (control, n = 2; SI, n = 3) as per
manufacturer’s protocol. For each animal staining was
performed in five tissue sections corresponding to the
five lobes of lung. Specimens were processed on the same
day to eliminate any variability in conditions. An independent pathologist performed a double-blinded examination of the tissue slides under a light microscope. A
total of 2000 cells were counted at magnification of X400
and the percentage of Ki67 positive cells were calculated.
Lung tissue lysate preparation

Fresh frozen lung lobe tissues with highest injury score
(n = 5) were homogenized using VWR® Mini Bead Mill
Homogenizer (VWR International LLC., Radnor, PA)
following manufacturer’s protocol. Briefly, frozen tissues
of two control and three SI animals were washed in cold
X1 PBS, and 30 mg of each tissue was placed separately
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in a 2 mL tube containing 2.8 mm ceramic beads and
750 μl of lysis buffer containing RIPA buffer (Thermo
Fisher Scientific Inc. Waltham, MA) and protease inhibitor cocktail (Sigma Aldrich Inc., St. Louis, MO) at room
temperature. The samples were homogenized at speed 4
for 60 s. This was followed by incubation in ice for 30 min
and centrifugation at 13,000 rpm for 20 min at 4 °C. Protein concentration was determined using Pierce™ BCA
(Bicinchoninic Acid) Protein Assay Kit (Thermo Fisher
Scientific Inc. Waltham, MA) following manufacturer’s
protocol.
Immunoblot analysis

Protein (50 μg) was separated by SDS‐ polyacrylamide
gel electrophoresis and transferred onto PVDF (polyvinylidene fluoride) membrane (Bio-Rad Lab Inc., Hercules, CA) by electro blotting. The membrane was blocked
with 5% nonfat dry milk in X1 TBST (50 mM Tris, pH
7.5, 150 mM NaCl, 0.01% Tween 20) for 1 h at room temperature. The membrane was then incubated in primary
antibody, IL-6 antibody (#ab6672, Abcam Inc, Cambridge, MA) or β-actin (#4970, Cell Signaling Technology
Inc., Danvers, MA) at 1:1000 dilution in X1 TBST with
5% bovine serum albumin (Sigma Aldrich Inc., St. Louis,
MO) overnight at 4 °C. The membrane was washed three
times with X1 TBST for 10 min each and incubated with
HRP‐conjugated secondary antibody (#7074, Cell Signaling Technology Inc., Danvers, MA) at 1:5000 dilution in
X1 TBST with 5% nonfat dry milk for 1 h at room temperature. Following washes in X1 TBST, proteins were
detected using the enhanced chemiluminescence system
(Bio-Rad Lab Inc, Hercules, CA).
Statistical analysis

Statistical analysis was performed using GraphPad prism
8. One-way ANOVA with Tukey’s post-hoc analysis and
paired t test were utilized to generate adjusted “p” values.
P-values < 0.05 were considered statistically significant.

Results
The study was divided in two phases. The first phase of
the study was performed to determine the optimal duration of smoke exposure required for the development of
ARDS. Animals were divided according to smoke inhalation time as shown in the flow diagram in Fig. 2. Smoke
inhalation for 1 h was designated as “SI 1 h” (n = 3) and
smoke inhalation for 2 h was designated as “SI 2 h”
(n = 18). Fifteen animals successfully completed smoke
inhalation (SI) experiment and survived 48 h post smoke
exposure, and six animals died during procedures due to
either anesthesia/surgical complications or smoke inhalation-related complication.
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Smoke inhalation reduced peripheral oxygenation in large
animal model

The SpO2 level was measured continuously on the day
of the smoke inhalation experiment and at 24 h- and
48 h- post smoke inhalation. The SpO2 level following
1 h- or 2 h- smoke inhalation was approximately 95%
and started to decrease at 24 h post smoke inhalation in
both groups. However, SpO2 level significantly dropped
in the SI 2 h group at 48 h post smoke exposure (68 ± 6%)
compared to baseline (98 ± 2%) and the SI 1 h group
(88 ± 4%) (Fig. 3A). The decrease was approximately
30% as reflected by the delta SpO2 (ΔSpO2) value in SI
2 h group compared 10% in the SI 1 h group (Fig. 3B). In
addition, at 48 h post smoke exposure PaO2/FiO2 ratio
was reduced approximately to 193.4 in the SI 2 h group
compared to baseline and SI 1 h group values (267–390)
(Figs. 3C, D). These results demonstrated that at 48 h
post smoke exposure, animals with smoke inhalation
for 2 h showed sign of respiratory distress as reflected
by decrease in S
 pO2 value below 68% and indicated that
there is injury to the lung.
For the rest of the study, we concentrated at the 2 h
time point for duration of smoke exposure, and repeated
experiments to ensure reproducibility of this model.
Animals were exposed to smoke for 2 h duration and
designated as “SI” animals. Consistent with the result in
Fig. 3, we observed a 22–40% decrease in SpO2 compared
to baseline values (Figs. 4A, B, p < 0.0001). In addition,
arterial and mixed venous oxygen saturation (SaO2 and
SmvO2) were reduced by approximately 39–43% compared to the corresponding baseline values (Figs. 4C, D,
p < 0.0001).
All results presented to follow are after 2 h smoke
exposure.
Smoke inhalation induced hypoxemia in large animal
model

Arterial blood gas (ABG) was measured from both
arterial and mixed venous blood samples throughout
the study. The arterial partial pressure of oxygen (PaO2)
level started to decrease 1 h after smoke exposure and
dropped significantly at 48 h post smoke exposure to
43 mmHg from baseline value of 95 mmHg (Fig. 5A).
Delta PaO2 (ΔPaO2) value in Fig. 5B showed a difference of 53 ± 5.8 mmHg (p < 0.0001). As expected,
there was a rise in partial pressure of carbon dioxide
(PaCO2) level (Fig. 5A) with an increase in ΔPaCO2
value by 27.5 ± 2.34 mmHg compared to the baseline
value (Fig. 5B, p < 0.0001). In correlation with findings from arterial samples, at 48 h post smoke exposure we observed significant reduction in the partial
pressure of mixed venous oxygen (ΔPmvO2) level
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Fig. 2 Flow diagram representing animals assigned to different study groups

(15.12 ± 2.12 mmHg) and corresponding increase
in partial pressure of mixed venous carbon dioxide
(ΔPmvCO2) level (19.23 ± 4.01 mmHg) compared to
the baseline values (Figs. 5C, D, p < 0.0001 to = 0.0005).
The pH level was also significantly decreased at 48 h
post smoke inhalation (Table 2, p < 0.001) with no significant change in the HCO3 levels (Table 2). Consistent
with the rise in PaCO2 value post smoke inhalation, end
tidal CO2 (ETCO2) – which measures the concentration
of CO2 exhaled at the endotracheal tube—significantly
increased from the baseline value of 33.9 ± 12.8 mmHg
to 52.63 ± 13.5 mmHg at 48 h post smoke inhalation
(Table 2, p = 0.009).
Previous studies have documented PaO2/FiO2 ratio
to assess the level of hypoxemia in the animal model
[17, 24]. We also demonstrated significant reduction in P
 aO2/FiO2 ratio at 48 h post smoke exposure
(198.87 ± 37.13), with 40% of animals having values

less than 170 (Fig. 6A). The difference in the ΔPaO2/
FiO2 value between the baseline and at 48 h post smoke
exposure was approximately 208 (Fig. 6B, p < 0.0001).
Furthermore, hematocrit (Hct), hemoglobin (Hb),
and fractional oxyhemoglobin (FO2Hb) values were
reduced 48 h after smoke inhalation compared to baseline (Table 2, p < 0.001 to = 0.02). As expected, total
arterial oxygen content (CaO2) and mixed venous oxygen content (CmvO2) of blood were also significantly
reduced 48 h after smoke inhalation compared to the
corresponding baseline values (Figs. 6C, D, p < 0.0001).
There were no significant changes in heart rate (HR),
temperature (Temp), mean arterial pressure (MAP) and
pulmonary arterial pressure (PAP) (Table 2).
Effect of smoke inhalation on lung parenchyma

Smoke inhalation has been reported to increase capillary leakage [25, 26]. Consistent with previous studies, we observed diffuse, bilateral infiltrates on repeated
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Fig. 3 Effect of smoke duration in large animal. A, B Peripheral oxygen saturation ( SpO2) level was measured in 1 h- and 2 h-smoke inhalation
groups designated as “SI 1 h” and “SI 2 h”, respectively, at different time points from 0 to 48 h. A Statistical analysis of the delta S pO2 (designated as
ΔSpO2) between SI 1 h and SI 2 h groups (B). ΔSpO2 for each group represented the difference in SpO2 level between baseline and 48 h post smoke
exposure. C, D The ratio of partial pressure of arterial oxygen (PaO2) and fraction of inspired oxygen (FiO2), designated as “PaO2/ FiO2” was measured
in SI 1 h and SI 2 h group of animals (C). Statistical analysis of the delta PaO2/FiO2 (designated as ΔPaO2/FiO2) between SI 1 h and SI 2 h groups (D).
ΔPaO2/FiO2 for each group represented the difference in PaO2/FiO2 level between baseline and 48 h post smoke exposure. Smoke inhalation started
at 0 h time point A p value of < 0.05 was considered statistically significant

radiographic assessment of lung injury with chest x-rays
in both ventral-dorsal and lateral views at 48 h after
smoke injury (Fig. 7A). In contrast, both lungs were
normal in the chest x-rays taken before smoke inhalation (Fig. 7A). Histologic examination of lung tissue 48 h
post smoke exposure showed an increase in the number
of leukocyte infiltration, intra-alveolar hemorrhage, and
alveolar edema compared to the control animal group
(Figs. 7B, C); and the overall lung injury score was significantly increased (Fig. 7D; p = 0.0376). We also observed
an increase in the average wet-dry weight (W/D) ratio
of lung tissues 48 h after smoke exposure (6.233 ± 1.14)
compared to the control animals (5.445 ± 0.36) (Fig. 7E,
p = 0.0091). Ki67 immunohistochemistry was performed

in paraffin embedded lung tissue sections of two control and two smoke inhalation animals. Lung tissue sections of animals at 48 h post smoke inhalation showed
a statistically significant decrease in the number of proliferative cells compared to the control animals (Fig. 7F,
p = 0.0292). Furthermore, BAL fluid samples taken from
six animals showed significant increase in the total protein concentration of BAL fluid 48 h post smoke inhalation compared to the baseline (Fig. 7G, p = 0.0436).
Effect of smoke inhalation on IL‑6 expression level

We observed a significant increase in IL-6 level in BAL
fluid samples at 48 h post smoke exposure (Fig. 8A,
p = 0.0102), and a marginal increase at 2 h time point

Leiphrakpam et al. Respir Res

(2021) 22:198

Page 9 of 15

Fig. 4 Smoke inhalation reduced oxygen saturation in large animals. A, B Peripheral oxygen saturation ( SpO2) level was measured in a different
set of 2 h smoke inhalation group designated as “SI” at different time points from 0 to 48 h. A ΔSpO2 values between baseline and different time
points (B). C, D Arterial oxygen saturation (SaO2) and mixed venous oxygen saturation (SmvO2) levels were measured in SI group at baseline, 2 h,
24 h, and 48 h time points (C). Delta S aO2 (ΔSaO2) and delta S mvO2 (ΔSmvO2) values were calculated between baseline and different time points
(D). Delta value for each parameter represented the difference with corresponding baseline values. S aO2 level was measured at 24 h for n = 8, SpO2
and SmvO2 levels were not measured at 24 h time point. Smoke inhalation started at 0 h time point. A p value of < 0.05 was considered statistically
significant

(Fig. 8A, p = 0.1010) compared to the baseline level. IL-6
immune assay analysis in plasma samples of 10 animals
also demonstrated a significant increase in IL-6 level in SI
animals at 2 h smoke inhalation compared to the baseline
(Fig. 8B, p = 0.0046). However, no significant increase
was observed in animals at 48 h post smoke inhalation
(Fig. 8B, p = 0.1934). Increased IL-6 expression level
obtained in BAL fluid and plasma sample immunoassay
analyses were further validated by the robust upregulation of IL-6 expression level in immunoblotting of lung
tissue lysates at 48 h post smoke inhalation in SI animals
compared to the control animals (Fig. 8C).

Discussion
ARDS arises from diverse insults in the lungs, and a variety of lung injury animal models have been developed to
study the pathophysiological processes [3, 27]. Frequently

used models for ALI includes intravenous infusion of
oleic acid [28, 29], repeated bronchoalveolar lavage with
saline [30, 31], and intravenous infusion of endotoxin [32,
33]. These models studied acute lung injury manifested
within 24 h. In the current model, we wished to focus on
the acute phase of injury after smoke inhalation; extrapolating from our experience with human smoke inhalation, the effects of smoke injury typically peak at 48–72 h
post-exposure. We did not desire to confound the current
study with sub-acute or chronic effects of ARDS. As such,
ours is an acute model and does not reflect the long-term
effects of ARDS, i.e. tissue remodeling and fibrosis.
Furthermore, no large animal models of ARDS from
isolated smoke inhalation injury exists in the literature.
Our main goal was to contribute to the scientific community by developing such a model that is reliable and
reproducible. Smoke inhalation is a major predisposing
factor for the development of ARDS and is considered
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Fig. 5 Smoke inhalation reduces PO2 with reciprocal increase in PCO2. Arterial partial pressure of oxygen (PaO2) and carbon-dioxide (PaCO2) levels
were measured in SI group at baseline, 2 h, 24 h, and 48 h time points (A). Delta P
 aO2 (ΔPaO2) and delta PaCO2 (ΔPaCO2) values between baseline
and different time points (B). Mixed venous partial pressure of pressure of oxygen ( PmvO2) and carbon dioxide (PmvCO2) level were measured in
SI group at baseline, 2 h, 24 h, and 48 h time points (C). Delta PmvO2 (ΔPmvO2) and delta PmvCO2 (ΔPmvCO2) values were calculated between
baseline and different time points (D). Delta value for each parameter represented the difference with corresponding baseline values. P
 aO2 and
PaCO2 levels were measured at 24 h for n = 8; PmvO2 and P
 mvCO2 levels were not measured at 24 h time line. Smoke inhalation started at 0 h time
point. A p value of < 0.05 was considered statistically significant

Table 2 Hemodynamic parameters
Parameters
Art pH
Art HCO3 (mmol/L)
ETCO2 (mmHg)
Hct (%)
Hb (g/dl)
FO2Hb (%)
HR (bpm)
Temp (0C)
MAP (mmHg)
PAP (mmHg)

Baseline
7.47 ± 0.07

SI 2 h
7.45 ± 0.07

Post SI 24 h
a
7.47 ± 0.04

Post SI 48 h
7.30 ± 0.10***

29.33 ± 2.19

30.42 ± 1.80

27.49 ± 3.02

30.09 ± 3.70

34.35 ± 2.82

34.02 ± 3.46

31.75 ± 2.99

29.58 ± 6.04*

95.35 ± 3.80

91.74 ± 7.89

–

37.18 ± 0.87

36.67 ± 4.43

–

15.25 ± 9.20

14.71 ± 10.2

–

33.90 ± 12.8

11.08 ± 0.84

87.17 ± 18.3

66.50 ± 26.8

40.56 ± 11.8

11.04 ± 1.15

92.91 ± 41.63

72.68 ± 12.8

–

10.37 ± 0.94

–
–

52.63 ± 13.5**
9.50 ± 1.89*

52.13 ± 16.4***
88.75 ± 12.88

41.27 ± 11.1

74.83 ± 19.0

23.84 ± 17.2

Values are calculated as mean ± SD, n = 13. Art pH, arterial pH; Art HCO3, arterial bicarbonate; ETCO2, end tidal carbon dioxide; Hct, hematocrit; Hb, hemoglobin;
FO2Hb, fractional oxyhemoglobin MAP, mean arterial pressure; PAP, pulmonary arterial pressure; HR, heart rate; Temp, temperature
** p < 0.01, *** p < 0.001, **** p < 0.0001
a

n=8
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Fig. 6 PaO2/FiO2 and total oxygen content reduced in smoke inhalation induced lung injury. A The ratio of P
 aO2 and FiO2, designated as “PaO2/FiO2”
was measured in SI group of animals at baseline, 2 h, 24 h, and 48 h time points. B Delta P
 aO2/ FiO2 (ΔPaO2/FiO2) values were calculated between
baseline and different time points. C Total arterial oxygen content (CaO2) and total mixed venous oxygen content (CmvO2) levels were measured in
SI group at baseline, 2 h, 24 h and 48 h time points. D Delta CaO2 (ΔCaO2) and delta CmvO2 (ΔCmvO2) values were calculated between baseline and
different time points (D). Delta value for each parameter represented the difference with the corresponding baseline values. P
 aO2/FiO2 and CaO2
and levels were measured at 24 h for n = 8 and n = 6 respectively; CmvO2 level was not measured at 24 h time line. Smoke inhalation started at 0 h
time point. A p value of < 0.05 was considered statistically significant

together with burn injury in several animal models for
smoke/burn injury-induced ARDS [17, 20–22]. However, there is no suitable large animal model available for
isolated smoke inhalation-induced ARDS that replicates
human ARDS without confounding variables such as
cutaneous burn injury.
The present study utilized oak wood to generate
smoke from the smoke generator. Oak wood is easily available and its composition and particle size has
been well -characterized [34, 35]. Additionally, commercially-available oak are compatible with the smoke
generator system used in the study. Oak wood is mainly
composed of cellulose (41–46%), hemicellulose (19–
22%) and lignin (29–30%), together with resins and variable amounts of water and inorganic matter [34]. Oak
wood generates ~ 2 g fine particulate per kg of wood
burned which composed primarily of organic carbon
(~ 50%) and elemental carbon (~ 3%), and also include

ions and elements [35]. Some of the organic compounds found in fine particle mass are levoglucosan
and other sugar derivatives, substituted syringols, guaiacol and substituted guaiacol, substituted benzene and
phenols, PAH and alkyl-PAH and phytosteroids [35].
We reported the development and validation of a large
animal model for isolated smoke inhalation-induced
ARDS. Following smoke exposure through an endotracheal tube, animal reproduced the entire set of clinical parameters for defining ARDS, such as significant
decrease in S
 pO2 to approximately 65%, mean PaO2/
FiO2 value of 196, diffuse bilateral pulmonary infiltrates
on chest X-rays at 48 h post smoke inhalation, and no
clinical evidence of cardiac failure or fluid overload as
explained by ARDS Definition Task Force, 2012 [7]. We
also documented significant decreases in P
 aO2 and the
reciprocal increase in P
 aCO2. Studies have shown that
increase in P
 aCO2 and E
 TCO2 levels correlate with the
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Fig. 7 Effect of smoke inhalation in lung parenchyma. A Ventral-dorsal and lateral view chest x-rays at baseline and 48 h after smoke inhalation.
Hematoxylin and eosin (H&E) staining on two sets of paraffin embedded lung tissue sections of control and SI animals (B). Statistical analysis of lung
injury score between control and SI animals (C, D). E Statistical analysis of wet/dry weight (W/D) ratio between control and SI animals. F Percentage
of Ki67 positive cells on the paraffin embedded lung tissue sections of control and SI animals. G Quantification of total protein concentration of BAL
fluid samples in SI group at baseline and 48 h post smoke inhalation. A p value of < 0.05 was considered statistically significant

presence of physiological dead space in lungs and the
increased in gradient between these two values corresponds with ARDS severity [36, 37]. We observed an

increase in the gradient (PaCO2–ETCO2) from 7.67 at
baseline to 14.21 at 48 h post smoke exposure. IL-6,
one of the inflammatory cytokines involved in the
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Fig. 8 Effect of smoke inhalation on IL-6 expression. A IL-6 expression level in BAL fluid samples of SI animals at baseline, 2 h and 48 h time points.
B IL-6 expression level in plasma samples of SI animals at baseline, 2 h and 48 h time points. C Immunoblot analysis of IL-6 expression level in fresh
frozen lung tissues of SI and control animals. A p value of < 0.05 was considered statistically significant

development of ARDS started to rise 2 h time point in
SI animals and sustained until 48 h in both plasma and
BAL fluid samples. IL-6 expression level was also significantly upregulated in fresh frozen lung tissue samples
of smoke exposed animals compared to control animals. We also observed a significant reduction of Ki67
positive cells in lung tissue of smoke exposed animals
compared to control tissue indicating smoke exposure
decreased normal lung parenchyma cell proliferation.
In addition, evidence of significant lung tissue injury
and inflammatory response to the injury were documented. These results indicated the deterioration of
respiratory functions in the diseased lungs from smoke
exposure.
Developing mimics of human ARDS in a large animal
model such as pig has clear advantages, such as the ability
to perform invasive procedures and serial blood analysis,
and feasibility of documenting the respiratory function
for an extended period of time. Moreover, monitoring
the respiratory parameters in a mechanically ventilated
animal allowed us to detail functional deterioration of
the animal in a controlled environment after smoke

inhalation. The detailed presentation of our model allows
for others in the scientific community to independently
confirm reproducibility, and hopefully use our model for
investigations leading to clinical translation.

Conclusion
We developed, for the first time, a novel large animal
isolated smoke inhalation-induced ARDS model which
mimics human ARDS and lacks confounding variables
such as cutaneous burn injury or intra-abdominal sepsis.
This model will help in better understanding the pathophysiological mechanisms involved in the process of
smoke inhalation-induced ARDS and aid in the development of novel therapeutic strategies.
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